Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02846779 · ClinicalTrials.gov registry record · NA
Targeted Adherence Intervention to Reach Glycemic Control With Insulin Therapy for Patients With Diabetes
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 6,000
- Enrollment target
NCT02846779 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 6,000 participants.
The verdict
NCT02846779, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 6,000 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate three pharmacist-outreach strategies for improving adherence to insulin among individuals with diabetes. The three approaches are equivalently-priced but vary by degree of targeting and intervention intensity.
Interventions
- OTHER Low intensity
- OTHER Moderate intensity
- OTHER High intensity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,000 participants |
| Start Date | 2016-07 |
| Est. Completion | 2018-02-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02846779
The ClinicalTrials.gov registry entry for NCT02846779 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Low intensity is the first listed.
NCT02846779 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02846779 about?
NCT02846779 is a clinical study titled "Targeted Adherence Intervention to Reach Glycemic Control With Insulin Therapy for Patients With Diabetes". The purpose of this study is to evaluate three pharmacist-outreach strategies for improving adherence to insulin among individuals with diabetes. The three approaches are equivalently-priced but vary by degree of targeting and intervention intensity.
What is the current status of trial NCT02846779?
This trial is currently completed. It is a NA study. The enrollment target is 6,000 participants. The study started on 2016-07. Estimated completion is 2018-02-10.
What interventions are being tested in trial NCT02846779?
The interventions under investigation include: Low intensity (OTHER), Moderate intensity (OTHER), High intensity (OTHER).
Who is sponsoring clinical trial NCT02846779?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.